Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin
Endocrine
.
2012 Dec;42(3):754-5.
doi: 10.1007/s12020-012-9677-0.
Authors
Ludovico Abenavoli
,
Natasa Milic
,
Francesco Capasso
PMID:
22527892
DOI:
10.1007/s12020-012-9677-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Diseases / complications*
Fatty Liver / complications*
Humans
Insulin Resistance / physiology*
Metabolic Syndrome / complications*